Rekha Jhunjhunwala is an Indian investor and businesswoman who was acknowledged for inheriting and managing the huge funding portfolio of her late husband, Rakesh Jhunjhunwala. As per the most recent company shareholdings filed, Rekha Jhunjhunwala publicly holds 26 shares with a internet value of over Rs. 38,150.0 crores.
Nazara Applied sciences Restricted gives gaming companies on a subscription foundation, together with downloading video games and assist, in addition to e-sports and promoting tech ecosystems. Nazara owns a number of IPs equivalent to World Cricket Championship, Kiddopia, Animal Jam, and SportsKeeda. Nazara additionally has workplaces in Dubai and Singapore.
The corporate reported a income of Rs 535 crores in Q3 FY25, up by 67 p.c from its Q3 FY24 income of Rs 320 crores. It posted a internet revenue of Rs 14 crores in Q3 FY25, a decline of 53 p.c, in opposition to a internet revenue of Rs 30 crores in Q3 FY24. As of This autumn FY25, Rekha Jhunjhunwala purchased a 7.1 p.c stake within the firm value Rs 622.6 crore.
Geojit Monetary Companies Restricted, established in 1987 and headquartered in Kochi, India, gives broking and monetary companies in India, Oman, Kuwait, the UAE, and Saudi Arabia. It’s engaged in Monetary Companies (brokerage, depository, portfolio administration) and Software program Companies (software program growth and upkeep) segments. It was beforehand referred to as Geojit BNP Paribas Monetary Companies Restricted till February 2017.
The corporate reported a income of Rs 172 crores in Q3 FY25, up by 13 p.c from its Q3 FY24 income of Rs 152 crores. It posted a internet revenue of Rs 37 crores in Q3 FY25, a decline of two.6 p.c, in opposition to a internet revenue of Rs 38 crores in Q3 FY24. As of This autumn FY25, Rekha Jhunjhunwala purchased a 7.2 p.c stake within the firm value Rs 154 crore.
Additionally learn: Reliance Industries Income Stream: Section-wise Income and Development Breakdown
Wockhardt Restricted, established in 1967 and having its headquarters in Mumbai, India, is a biotech and pharmaceutical firm with world operations. It produces infectious illness medicines, together with a few of them in Section 3 trials, and markets insulin merchandise, biopharmaceuticals equivalent to Biovac-B and WEPOX, and new drug supply gadgets. Wockhardt additionally provides contract manufacturing and manufactures energetic pharmaceutical components (APIs).
The corporate reported a income of Rs 721 crores in Q3 FY25, up by 2.85 p.c, from its Q3 FY24 income of Rs 701 crores. The corporate turned worthwhile, reporting a internet revenue of Rs 20 crores in Q3 FY25, in comparison with a internet lack of Rs 86 crores in Q3 FY24. As of This autumn FY25, Rekha Jhunjhunwala purchased a 1.8 p.c stake within the firm value Rs 395.3 crore.
Written by Satyajeet Mukherjee
Disclaimer
The views and funding suggestions expressed by funding specialists/broking homes/score businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of economic losses. Buyers should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the creator are usually not chargeable for any losses brought on because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
